Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Doc,

Slides:



Advertisements
Similar presentations
Good Medical Practice Evidence to use for Appraisal Good Medical Practice 2006.
Advertisements

Local Government Services and revenue.
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
The Physician-Pharmaceutical Industry Relationship.
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
Conflict of Interest in Physician-Industry Relationships
Commercial support is defined as financial or in- kind contributions given by a commercial interest, which is used to pay all or part of the costs of a.
Merck and River Blindness
1 WORI Microfinance Loan Training December Introduction Today we will teach you all about the loan process. By the end of the day we want you.
CPME Comité Permanent des Médecins Européens Standing Committee of European Doctors Doctors and industry - European perspective International.
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
DOCTOR / DOCTOR AND DOCTOR PATIENT RELATIONSHIPS Idara C.E,
JOB FUNCTION EVALUATION Lowering Your Accident Costs.
Enforcement in the Pharmaceutical Industry Michael K. Loucks First Assistant U.S. Attorney United States Attorney’s Office District of Massachusetts October.
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
Occupational Health and Safety Part 2 - Committees, Worker’s Rights, Worker’s Compensation.
(rev 3/09) Stewardship, Accountability and Regulatory Compliance Jim Corkill Sandra Featherson Office of the Controller.
JOB SUCCESS SKILLS SALARY NEGOTIATION. 2 PRE-TEST (True – False) 1.There are five (5) stages of employer thinking. 2.You should “talk” salary as early.
Module Two. Purpose Simulation type activity of how to conduct a Student Session Provide information on the events of the day Agenda Student Mission Possible.
Careers in Pharmaceutical Sales Jim O’Bryan Great Lakes Regional Recruiter Field Sales Division Jim O’Bryan Great Lakes Regional Recruiter Field Sales.
External Influences on Prescribing Practice Karen Ford.
IMPLEMENTING AN EMERGENCY DEPARTMENT SCRIBE PROGRAM AT ALASKA REGIONAL HOSPITAL A Feasibility Study.
Principles of medical ethics Lecture (4) Dr. rawhia Dogham.
Conflict of Interest Curriculum Eric Jackson, PharmD University of Connecticut School of Medicine Department of Family Medicine.
CHCWG DRAFT March 2, 2006 Hearing from the American People: Preliminary Overview of Sources and Reports March 2006 Caution: Preliminary Data Do not cite.
Clinical Pharmacology Jim Wright Clinical Pharmacologist 7 lectures.
Put your organisation’s logo here. Conflicts of Interest A conflict occurs when the interests of one role/ position/ relationship are not aligned with.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
ELEMENT 3 - EMPLOYEE INVOLVEMENT 20. ____ There is a process designed to involve employees in safety and health issues. Enough can't be said about the.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Role of Industry in Clinical Care, Research and Education Rev 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
Just say no to drug reps. The Physician-Pharmaceutical Industry Relationship.
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
Todd Hamilton District Sales Manager. Innovation  On average it takes scientists, physicians, engineers, and other researchers between 10 and 15 years.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.
+ Conflict of Interest in Physician-Industry Relationships.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
+ Role of Industry in Clinical Care, Research, and Education.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
UNM INTERNAL MEDICINE RESIDENCY PROGRAM - HOSPITALIST TRAINING TRACK UNM Hospital Medicine Spring Retreat 2 June 2015 Charles Pizanis Patrick Rendon.
JOB SUCCESS SKILLS SALARY NEGOTIATION. Objective At the conclusion of this lesson, the student will be able to determine the most effective method for.
Copyright © Harvard Medical School. All Rights Reserved. Outside Activity Report: What Do I Need to Report?
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
National Medtrans Network & CenterLight NON EMERGENCY MEDICAL DRIVER ORIENTATION / INSERVICE Day:____________Date:____________.
MEDICAL STUDENT TRANSITION COURSE Professionalism in the Clinical Environment ANTHONY A. MEYER, MD, PHD CHAIRMAN, DEPARTMENT OF SURGERY UNIVERSITY OF NORTH.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Warm-up List 5 influences on your choice of health care products or services. Circle the two that most often affect your decisions Remember yesterday we.
Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
Principles of medical ethics Lecture (4) Dr. HANA OMER.
1 Stewardship, Accountability and Regulatory Compliance October 22, 2015 Stewardship, Accountability and Regulatory Compliance Jim Corkill | Controller.
Compensation Plan & Incentive Pay Making Sense of X,Y, and Z New Faculty Orientation UCSF Radiology and Biomedical Imaging Session 1: September 17, 2014.
0 Case Study Learning Curve. ACADEMY OF OPHTHALMOLOGY Financial Disclosure The speaker has no financial interest in the subject matter.
Pharmaceutical industry interactions in family medicine residencies have decreased since 2008 Steven R. Brown, MD, David V. Evans, MD, Adriane Fugh-Berman,
DOCTOR / DOCTOR AND DOCTOR PATIENT RELATIONSHIPS Idara C.E,
PTA Gifting Guidelines 5.Committee meets and decides what to recommend for funding. 6.Committee report goes to the executive board for approval. 7.Finalized.
Customer Satisfaction Doctors’ Arm Perceptual Mapping Tracker
The IVD Australia Code of Conduct Edition 2.1
Disclosure UK Talking about Transparency.
Employees Standards of Business Conduct - incorporating statutory guidance on conflicts of interest How does it affect me? This document is intended to.
PHARMACIST : A HEALTH CARE PROFESSIONAL
Disclosure UK Talking about Transparency.
Research for all Sharing good practice in research management
Industry Induction Course
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Client’s Rights & Choices
Presentation transcript:

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Doc, The Drug Rep and The Ward Rounds Or everything you wanted to know about pharmaceutical marketing but was afraid to ask. By: Amer K. Ardati, MD Editor: Amy Shaheen, MD, Assistant Professor of Clinical Medicine Duke University Medical Center

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Them Introductions Pharmaceuticals as a business Detailing Drugs to Docs –Costs of detailing to docs –Influence of detailing on docs –Perception of physicians and patients about drug detailing –What the academy and industry has to say about drug detailing. Conclusions and Questions

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Business of Drugs Pharmaceutical companies are for profit entities with a fiduciary responsibility to obtain profits for their shareholders. The drug industry is highly profitable when compared to others. The drug industry invests more in marketing than in research and development.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Business of Drugs Source: Public Citizen 2002: accessed 9/1/05http://

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Business of Drugs Source: Public Citizen 2002: accessed 9/1/05http://

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Business of Drugs Source: Public Citizen 2002: accessed 9/1/05http://

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum The Business of Drugs Source: PhRMA, Industry Profile Calculations by Sager and Socolar

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs More than $11 billion is spent each year by pharmaceutical companies in promotion and marketing, $5 billion of which goes to sales representatives. It has been estimated that $8000 to $13,000 is spent per year on each physician. The money is well spent and does influence prescribing patterns. JAMA 2000: 283;373

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs Unlike advertising, gifts and hospitality promote a sense of obligation towards the gift giver and encourages reciprocation of the gesture. This creates a conflict of interest.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs Physicians recognize that gifts influence other doctors but not themselves. Patients perceive drug gifts as a form of bribe against their interests regardless of whether or not the bribe is effective.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs From a review of 29 studies evaluating physician-industry interactions: –Most physicians meet with drugs reps 4 times a month. –Most physicians believe that drug representatives provide accurate information. JAMA 2000: 283;373

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs From a review of 29 studies evaluating physician-industry interactions: –Most physicians deny that interactions influence their behavior. JAMA 2000: 283;373

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs In a survey of 102 medical residents, most respondents felt that they were immune to drug representative marketing, while their colleagues were vulnerable. Am J Med: 2001: 110; 551

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs Am J Med: 2001: 110; 551

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs In a case control study of physicians requesting formulary additions at an academic hospital, physicians who met with pharmaceutical representatives were more likely to have requested addition of drugs made by those companies OR=4.9, 95%CI, JAMA 1994;271:684

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs In a survey of 468 physicians (both academic and community) a significant positive correlation was found between physician cost of prescribing and perceived credibility, availability, applicability, and use of information provided by pharmaceutical representatives. Arch Fam Med 1996: 5;201

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs In a survey of 196 patients and 268 physicians at two tertiary care centers, 54% of patients were aware that doctors received gifts from drug representatives, but only 27% thought that their doctors received gifts. Patients were more likely than physicians to feel that gifts influenced medical practice. JGIM 1998; 13:151

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs JGIM 1998; 13:151

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs JGIM 1998; 13:151

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs Drug detailing is an orchestrated endeavor. Here is an example of a drug detailing training manual from Merck that was obtained by the House Committee on Government Reform hearing on Rofecoxib (Vioxx): Harper’s 2005; 311: 16

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs The Merck Manual: –“Health Education Learning [HEL] Situation: Physician Says: What a great football game yesterday. Did you see how effective Drew Bledsoe was in the fourth quarter? That guy is amazing. Possible rep response: Bledsoe is effective on so many levels. He’s a leader, you feel safe with him carrying the ball, and he’s a proven winner. You know who else he sounds like? Zocor, a market leader with an eight-year safety record, proven to save lives of your patients…” Harper’s 2005; 311: 16

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs Policy Recommendations and Guidelines

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs The AMA Position: –“Any gifts accepted by physicians individually should primarily entail a benefit to patients and should not be of substantial value.” –“Subsidies from industry should not be accepted directly or indirectly to pay for the costs of travel, lodging, or personal expenses of the physicians who are attending the conferences and meetings...” –“No gifts should be accepted if there are strings attached.” JAMA 1991: 261;501

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs The ACP position: –The acceptance of individual gifts, hospitality, trips, and subsidies of all types from industry by an individual physician is strongly discouraged. –Physicians should not accept gifts, hospitality, services, and subsides form industry if acceptance might diminish or appear to others to diminish the objectivity of professional judgment. Annals 2002: 136; 396

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs The ACP position: –Acceptable Industry Gifts: Inexpensive gifts for office use (pens and calendars). Low cost gifts of an educational or patient-care nature (such as textbooks). Modest refreshment. Annals 2002: 136; 396

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs AMSA’s Position: –BELIEVES that practicing physicians should maintain an independent financial posture vis-a-vis the pharmaceutical industry to avoid the potential of conflict of interests in prescribing for and treating their patients –URGES all physicians, residents and medical students not to accept as end recipients any promotional gifts from the pharmaceutical industry. –URGES all hospitals and residency programs to discontinue the practice of pharmaceutical company- funded lectures and lunches. accessed 8/31/05

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs AMSA’s Position: –URGES all physicians not to accept honoraria on behalf of pharmaceutical companies for speaking at educational conferences and not to accept compensation for token consulting or advising. –SUPPORTS including curricula in medical school education concerning the ethics of physician-industry interactions, particularly in relation to pharmaceutical research and marketing. accessed 8/31/05

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs PhRMA’s (The pharmaceutical industry) Position: –Items primarily for the benefit of patients may be offered to healthcare professionals if they are not of substantial value ($100 or less). –Items of minimal value may be offered if they are primarily associated with a healthcare professional’s practice. –Items intended for the personal benefit of healthcare professionals (CDs, tickets to a sporting event) should not be offered. accessed 8/31/05.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs The Duke Position: –Representatives may sponsor or attend educational conferences with Duke faculty, trainees… upon prior approval by the program director, clinic director or conference organizer. –Promotional materials (e.g. all branded office supplies, personal items such as coffee mugs, bags, calendars, note pads) and other devices will not be distributed within Duke Hospital, Duke Clinics or the PDC clinics. accessed 8/31/05.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Detailing Drugs to Docs The Duke Position: –No advertisements should be posted on walls, doors, windows, and cabinets or placed in reception area(s). –Financial support directly to housestaff, fellows and students is prohibited. accessed 8/31/05.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Conclusions The pharmaceutical industry is in the business of selling drugs to make money. Drug marketing influences the way we treat our patients. Our patients know that drug marketing exists and that it affects the way we care for them.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Conclusions Academic societies have recognized this conflict of interest and have made varying attempts to manage this conflict. As a group we need to be more cognizant of the power of marketing to cloud our judgment.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question 1 Congrats! You have been elected chief medical resident and have to manage noon conference lunches for the next year. During last year as a GI fellow you got to know the Astra Zeneca Drug Rep while at the AGA meeting. She calls and asks if she could sponsor a talk in Peptic Ulcer Disease to your residents. She offers to bring lunch, pens, mugs, and a stack of tickets to go see Justin Timberlake at the RBC Center in Raleigh.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question 1 (cont.) Based on what you know about Duke’s Rules you decide to tell her: A) Sure come on down, the interns are hungry, my ACR stole all my pens, and Justin is dreamy. B) Thanks, but I can’t have you do the talk or pass out gifts. If you want to buy us lunch we may be able to work things out with my boss. C) No way! After Janet Jackson’s wardrobe malfunction, I wouldn’t feel Justified. Besides, couldn’t you use that money to pay for Malaria drugs in Africa?

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Answer 1 The answer is B. According to Duke rules, the drug rep cannot bring gifts. She may sponsor lunch, if the program director and chair agree. Wouldn’t it be nice if the $11 billion spent by drug companies to advertise to us were spent on saving lives?

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question 2 Your have just graduated from your Allergy and Immunology fellowship and finally have to work for a living. You move to Columbus, OH where the Buckeye Allergens are high enough to support your career in treating allergic rhinitis. The Schering representative drops by your office and notices that your golf clubs are looking kind of ratty. He offers to hook you up with a new set of clubs and a membership at the Country Club in exchange for your advice on the advantages of Clarinex.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question 2 (cont.) Based on what you know about the ACP and PhRMA’s guidelines on drug marketing you tell him: A) Could you please arrange for a 3PM tee time Monday- Friday I like to get a game in after a hard day in the office. B) My golf game is kind of weak, could you throw in a couple of lessons. C) Sorry I can’t take your bribe, ahem, gift.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Answer 2 The answer is C. Gifts should be of an educational nature and should benefit patient care. PhRMA’s voluntary guidelines recommend that the value of gifts not exceed $100. The ACP says that docs “should not accept gifts, hospitality, services, and subsides form industry if acceptance might diminish or appear to others to diminish the objectivity of professional judgment.”

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Questions 3, 4, and 5 background You’ve just finished Gen Med Duke as an intern and have CAD and 9090 to look forward to. As you try to figure out how much of your well earned paycheck to invest in PfizerMerckSchering and Co, you try to remember how these companies spend their money.

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Questions 3, 4, and 5 Match the following numbers with the correct description: $11bnAmount of total revenue spent on Research and Development 14%Amount of total revenue that is diverted to profits 17%Amount of total revenue spent on advertising drugs

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Answers 3, 4, and 5 Answers $11Bn is spent on marketing drugs each year 14% of drug company revenue is spent on research and development 17% is spent on profits Be sure to complete the evaluation (next slide)!!!

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Please click here to complete the course evaluation